OBJECTIVES: To describe the clinical presentation and long-term follow-up of a large cohort of patients with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. STUDY DESIGN: A nationwide, retrospective analysis of clinical presentation and follow-up in 155 Dutch patients with MCAD deficiency. RESULTS: Most patients presented between 3 months and 5.1 years of age; 13% had symptoms as neonates not exclusively related to breast-feeding. An acute presentation before the diagnosis was made resulted in a mortality of 22% (25/114), whereas 21% (19/89) developed disabilities after the diagnosis. On follow-up, a total of 44 patients reported fatigue (35%; 28/80), muscle pain (31%; 25/80), and/or reduced exercise tolerance (39%; 31/80). Cardiac evaluation in 11 adult patients revealed no abnormalities in cardiac function explaining these complaints. Children with MCAD deficiency readily become overweight. CONCLUSIONS: Mortality and morbidity were high in undiagnosed children with MCAD deficiency; establishment of the diagnosis significantly improves outcome. Strikingly, after the diagnosis and initiation of treatment, overweight and chronic complaints (fatigue, muscle pain, and reduced exercise tolerance) were prominent.
OBJECTIVES: To describe the clinical presentation and long-term follow-up of a large cohort of patients with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. STUDY DESIGN: A nationwide, retrospective analysis of clinical presentation and follow-up in 155 Dutch patients with MCAD deficiency. RESULTS: Most patients presented between 3 months and 5.1 years of age; 13% had symptoms as neonates not exclusively related to breast-feeding. An acute presentation before the diagnosis was made resulted in a mortality of 22% (25/114), whereas 21% (19/89) developed disabilities after the diagnosis. On follow-up, a total of 44 patients reported fatigue (35%; 28/80), muscle pain (31%; 25/80), and/or reduced exercise tolerance (39%; 31/80). Cardiac evaluation in 11 adult patients revealed no abnormalities in cardiac function explaining these complaints. Children with MCAD deficiency readily become overweight. CONCLUSIONS:Mortality and morbidity were high in undiagnosed children with MCAD deficiency; establishment of the diagnosis significantly improves outcome. Strikingly, after the diagnosis and initiation of treatment, overweight and chronic complaints (fatigue, muscle pain, and reduced exercise tolerance) were prominent.
Authors: Hidde H Huidekoper; Mariëtte T Ackermans; René Koopman; Luc J C van Loon; Hans P Sauerwein; Frits A Wijburg Journal: J Inherit Metab Dis Date: 2012-09-14 Impact factor: 4.982
Authors: Kristi Bentler; Shaohui Zhai; Sara A Elsbecker; Georgianne L Arnold; Barbara K Burton; Jerry Vockley; Cynthia A Cameron; Sally J Hiner; Mathew J Edick; Susan A Berry Journal: Mol Genet Metab Date: 2016-07-15 Impact factor: 4.797
Authors: Gwendolyn Gramer; Gisela Haege; Junmin Fang-Hoffmann; Georg F Hoffmann; Claus R Bartram; Katrin Hinderhofer; Peter Burgard; Martin Lindner Journal: JIMD Rep Date: 2015-05-05
Authors: Gabriella A Horvath; A G F Davidson; Sylvia G Stockler-Ipsiroglu; Yolanda P Lillquist; Paula J Waters; S Olpin; B S Andresen; Jan Palaty; Judie Nelson; Hilary Vallance Journal: Can J Public Health Date: 2008 Jul-Aug
Authors: Christina B Pedersen; Steen Kølvraa; Agnete Kølvraa; Vibeke Stenbroen; Margrethe Kjeldsen; Regina Ensenauer; Ingrid Tein; Dietrich Matern; Piero Rinaldo; Christine Vianey-Saban; Antonia Ribes; Willy Lehnert; Ernst Christensen; Thomas J Corydon; Brage S Andresen; Søren Vang; Lars Bolund; Jerry Vockley; Peter Bross; Niels Gregersen Journal: Hum Genet Date: 2008-06-04 Impact factor: 4.132